Sort
8,912 grants matching “sars cov 2”
At the Intersection of HIV and COVID-19: Medicaid Data as a Complement to Cohort Studies
$743,601Bryan Lau · Johns Hopkins University · R01 · FY2023 · AI
Human coronavirus infection of the nasal epithelium
$743,489Susan R. Weiss · University Of Pennsylvania · R01 · FY2023 · AI
Cross-Disease Multi-Modality Mapping of the Human Lung
$743,401Xin Sun · University Of California, San Diego · U01 · FY2025 · HL
Development of a novel adjuvant strategy enabled by modulation of the physical properties of fungal mannans
$743,329Ivan Zanoni · Boston Children'S Hospital · R01 · FY2024 · AI
Natural Killer cells and the Immunogenetics of COVID-19
$742,765Paul John Norman · University Of Colorado Denver · R01 · FY2021 · AI
Intensifying Community Referrals for Health: The SINCERE Intervention to Address COVID-19 Health Disparities
$742,753Andrea Schneider Wallace · University Of Utah · R01 · FY2022 · NR
Mobile Health to Monitor Risk for COVID-19 and Improve Mental Health during the Pandemic
$742,677Michael J Zvolensky · University Of Houston · R01 · FY2023 · MH
The Impact of SARS-CoV-2 Immune Dysregulation on Antifungal Immunity
$742,499Sixto Manuel Leal · University Of Alabama At Birmingham · R01 · FY2023 · AI
Immune Monitoring Core
$742,429Andrew S. Neish · Emory University · U54 · FY2020 · CA
Developing recombinant coronavirus vaccines for SARS
$742,409University Of Arkansas Med Scis Ltl Rock · U01 · FY2005 · AI
Developing a Multi-epitope Pan-Coronavirus Vaccine
$742,241Lbachir Benmohamed · University Of California-Irvine · R01 · FY2023 · AI
Rational design and evaluation of novel mRNA vaccines against MERS-CoV
$742,199Lanying Du · Georgia State University · R01 · FY2022 · AI
Targeting abnormal alveolar immune activation and failed epithelial repair in COVID-19
$742,194Alexander Misharin · Northwestern University At Chicago · R01 · FY2022 · HL
Targeting abnormal alveolar immune activation and failed epithelial repair in COVID-19
$742,194Alexander Misharin · Northwestern University At Chicago · R01 · FY2023 · HL
Role of mitochondrial extracellular vesicles in CVB3 myocarditis by sex
$742,061Delisa Fairweather · Mayo Clinic Jacksonville · R01 · FY2023 · HL
Studies in the Pathogenesis of Systemic Capillary Leak Syndrome
$742,042Kirk Druey · National Institute Of Allergy And Infectious Diseases · ZIA · FY2021 · AI
Development of lung T cell responses in infant respiratory immunity
$741,976Donna L Farber · Columbia University Health Sciences · U01 · FY2021 · AI
Micro Analytical Immunochemistry
$741,947Heather Kalish · National Institute Of Biomedical Imaging And Bioengineering · ZIC · FY2021 · EB
Cardiac microstructure and the immune-inflammatory response to SARS-CoV-2
$741,942Susan Cheng · Cedars-Sinai Medical Center · R01 · FY2023 · HL
Inborn errors of immunity in patients with life-threatening COVID-19
$741,871Jean-Laurent Casanova · Rockefeller University · R01 · FY2023 · AI
Initiation of immune responses to SARS COV2 in the oral cavity and upper airway
$741,811Sarah C Glover · Tulane University Of Louisiana · R01 · FY2025 · DE
Involvement Of Human Viruses Associated With Chronic Neurologic Disease
$741,698Steven Jacobson · National Institute Of Neurological Disorders And Stroke · ZIA · FY2023 · NS
Development of dual inhibitors targeting the viral main protease and the host cathepsin L as SARS-CoV-2 antivirals
$741,356Jun Wang · Rutgers Biomedical And Health Sciences · R01 · FY2022 · AI
Quantitative Detection of Coronary Microvascular Dysfunction in Long COVID Patients using a Comprehensive, Rapid, Free-Breathing Cardiovascular MRI
$741,023Daniel Kim · Northwestern University At Chicago · R01 · FY2024 · HL
Immunological drivers of the transition from epidemicity to endemicity of SARS-CoV-2 in a high transmission LMIC setting
$741,011Albert Icksang Ko · Yale University · R01 · FY2024 · AI